124
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 131-140 | Published online: 15 Apr 2020

References

  • Ansell SM. Non-hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc. 2015;90:1152–1163.26250731
  • Lamar ZS, Dothard A, Kennedy L, et al. Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-hodgkin lymphoma is prevalent and associated with chemotherapy alteration – a retrospective study. Leuk Lymphoma. 2018;59(8):1871–1877. doi:10.1080/10428194.2017.141088929252084
  • Perez A, Jansen-Chaparro S, Saigi I, et al. Glucocorticoid-induced hyperglycemia. J Diabetes. 2014;6(1):9–20. doi:10.1111/1753-0407.1209024103089
  • Donihi AC, Raval D, Saul M, et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12(4):358–362. doi:10.4158/EP.12.4.35816901792
  • Fong AC, Cheung NW. The high incidence of steroid-induced hyperglycaemia in hospital. Diabetes Res Clin Pract. 2013;99(3):277–280. doi:10.1016/j.diabres.2012.12.02323298665
  • Brunello A, Kapoor R, Extermann M. Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. Am J Clin Oncol. 2011;34:292–296. doi:10.1097/COC.0b013e3181e1d0c020622641
  • Suh S, Park MK. Glucocorticoid-induced diabetes mellitus: an important but overlooked problem. Endocrinol Metab (Seoul). 2017;32:180–189. doi:10.3803/EnM.2017.32.2.18028555464
  • Tamez-Pérez HE, Quintanilla-Flores DL, Rodríguez-Gutiérrez R, et al. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6:1073–1081. doi:10.4239/wjd.v6.i8.107326240704
  • Kwon S, Hermayer KL, Hermayer K. Glucocorticoid-induced hyperglycemia. Am J Med Sci. 2013;345(4):274–277. doi:10.1097/MAJ.0b013e31828a6a0123531958
  • Gonzalez-Gonzalez JG, Mireles-Zavala LG, Rodriguez-Gutierrez R, et al. Hyperglycemia related to high-dose GC use in noncritically ill patients. Diabetol Metab Syndr. 2013;5:18. doi:10.1186/1758-5996-5-1823557386
  • Lee SY, Kurita N, Yokoyama Y, et al. Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy. Support Care Cancer. 2014;22:1385–1390. doi:10.1007/s00520-013-2097-824362844
  • van Raalte DH, Nofrate V, Bunck MC, et al. Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. Eur J Endocrinol. 2010;162:729–735. doi:10.1530/EJE-09-103420124412
  • Trence DL. Management of patients on chronic glucocorticoid therapy: an endocrine perspective. Prim Care. 2003;30:593–605. doi:10.1016/S0095-4543(03)00038-114692203
  • American Diabetes Association 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42:S13–S28. doi:10.2337/dc19-S00230559228
  • Pichardo-Lowden AR, Fan CY, Gabbay RA. Management of hyperglycemia in the non-intensive care patient: featuring subcutaneous insulin protocols. Endocr Pract. 2011;17(2):249–260. doi:10.4158/EP10220.RA21041168
  • Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33(7):1624–1633. doi:10.1097/01.CCM.0000170106.61978.D816003073
  • Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–982. doi:10.1210/jcem.87.3.834111889147
  • Bonaventura A, Montecucco F. Steroid-induced hyperglycemia: an underdiagnosed problem or clinical inertia? A narrative review. Diabetes Res Clin Pract. 2018;139:203–220. doi:10.1016/j.diabres.2018.03.00629530386